SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : SAFESKIN -- Ignore unavailable to you. Want to Upgrade?


To: t36 who wrote (226)3/10/1998 6:58:00 PM
From: wmf  Read Replies (1) | Respond to of 828
 
Here are the key ratio for Safeskin:

5 Yr. Range Current
P/E 9 - 47 43
Price to Book 3.6 - 19.4 17.8
Price to Cash Flow 6.7 - 40.2 36.8
Price to Sales 1 - 9.5 8.71
Return on Equity 24% - 58.9% 36.4%

Can they keep going like this ? Very possible. There are enough expensive stocks out there which keep getting more expensive. Is SFSK it an enticing story ? Clearly yes. Is is safe to buy a stock at the upper limit of such wide valuation ranges ? Everybody has to decide him/herself. A stock split does not help the valuation situation and unfortunately I have suffered myself through situations where the stock went South in the weeks and months AFTER the split.